It doesn't seem to be rich vs poor countries in this case. The Moderna vaccine is expensive. Too expensive, even for some developed countries that rejected it as an option.
If the US government is happy to hand out billions in funding and then pay a high price for the doses, why would a private company not take advantage of this?
Somehow the EU/UK convinced AstraZeneca to sell the Oxford vaccine at production cost.
If the US government is happy to hand out billions in funding and then pay a high price for the doses, why would a private company not take advantage of this?
Somehow the EU/UK convinced AstraZeneca to sell the Oxford vaccine at production cost.